Website & contact details
- Website
Synexa Life Sciences Ltd
- Incorporated
- 11 October 2012 (14 years)
- Industry
- Other research and experimental development on natural sciences and engineering (72190)
- Directors
- James Walter Lloyd
- Accounts type
- Small
- Region
- North West
- Address
- Alderley Court Larkwood WayTytherington Business ParkMacclesfieldSK10 2XR
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 25 October 2027
- Last conf. stmt
- 11 October 2026
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 2 active
Officer details are public data from the Companies House register.
British
Born February 1973 (53)
Lloyd, James Walter
Director · Appointed 25 August 2026
British
Born August 1983 (43)
Officer history (4 former)
31 August 2026
Resigned Lens, Emile Andre as Director
25 August 2026
25 August 2026
Appointed Lloyd, James Walter as Director
25 August 2026
Resigned O'Riordan, Paul Desmond as Director
8 November 2019
Appointed Lens, Emile Andre as Director
8 November 2019
Resigned Kimberg, Matti as Director
10 April 2019
Appointed Kimberg, Matti as Director
27 February 2015
Resigned Snyman, Jo-Ann Magdelene as Director
2 January 2015
Appointed Snyman, Jo-Ann Magdelene as Director
11 October 2012
Appointed O'Riordan, Paul Desmond as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Holdings 1
Companies where Synexa Life Sciences Ltd is registered as a person with significant control
Owns 75–100% of shares
Active
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £381,647
- Cash
- £154,536
- Debt Ratio
- 96%
- Current Ratio
- 0.3x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2020 | 2019 | |
|---|---|---|---|---|
| Fixed Assets | £6,404,461 | £375,571 | £360,543 | £320,681 |
| Current Assets | £2,156,252 | £3,374,119 | £715,890 | £1,507,472 |
| Debtors | £1,952,682 | £3,188,580 | £524,040 | £1,382,223 |
| Cash | £154,536 | £118,356 | £99,336 | £60,347 |
| Creditors (< 1 year) | £7,857,950 | £3,045,537 | £1,884,685 | £2,903,734 |
| Creditors (> 1 year) | £242,099 | £146,433 | ||
| Net Current Assets | (£5,701,698) | £328,582 | (£1,168,795) | (£1,396,262) |
| Net Assets | £381,647 | £478,703 | ||
| Shareholder Funds | £381,647 | £478,703 | (£808,252) | (£1,075,581) |
What Synexa Life Sciences say about themselves
“Synexa Life Sciences is a biomarker and bioanalytical lab clinical research organisation (CRO). Discover our solutions to advance your therapeutic pipelines.”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 1 September 2026 | Appointment of a director | |||
| 1 September 2026 | Appointment of a director | |||
| 1 September 2026 | Termination of appointment of a director | |||
| 1 September 2026 | Termination of appointment of a director | |||
| 26 August 2026 | Accounts for a small company | 31 December 2025 |
Other companies in this industry
Cambridge
Coventry
Weybridge
Stevenage
Reading
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →